ENSC
NASDAQ
US
Ensysce Biosciences, Inc. - Common Stock
$0.61
▲ +$0.06
(+11.52%)
Vol 231K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$3.3M
ROE
-386.7%
Margin
-244.5%
D/E
32.22
Beta
1.12
52W
$1–$11
Wall Street Consensus
7 analysts · Jul 20242
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%
Next Report
May 11, 2026
EPS Estimate: $-0.84
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.84 | — | — |
| Sep 2025 | $-0.88 | $-1.29 | $-0.41 |
| Jun 2025 | $-1.20 | $-0.79 | +$0.41 |
| Mar 2025 | $-3.08 | $-1.39 | +$1.69 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | $662K | -$3.6M | -$1.9M | -$1.7M | -$3.7M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -154.4% | -176.2% | -154.4% | -154.4% | -154.4% | -386.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -126.4% | -109.5% | -88.8% | -88.8% | -88.8% | -244.5% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 12.53 | 8.44 | 12.53 | 12.53 | 12.53 | 32.22 |
| Current Ratio | 2.10 | 2.50 | 2.10 | 2.10 | 2.10 | 1.27 |
Key Ratios
ROA (TTM)
-231.5%
P/S (TTM)
0.74
P/B
2.2
EPS (TTM)
$-6.36
CF/Share
$-7.50
Rev Growth 3Y
+13.9%
52W High
$10.96
52W Low
$1.08
$1.08
52-Week Range
$10.96
Financial Health
Free Cash Flow
-$2.0M
Net Debt
-$1.3M
Cash
$1.7M
Total Debt
$388K
As of Sep 30, 2025
How does ENSC compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ENSC valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0.7
▼
94%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
2.2
▼
11%
below
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ENSC profitability vs Biotechnology peers
ROE
-386.7%
▼
475%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-244.5%
▲
15%
above
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-231.5%
▼
396%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
ENSC financial health vs Biotechnology peers
D/E ratio
32.2
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
1.3
▼
71%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.1
▲
16%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
ENSC fundamentals radar
ENSC
Peer median
Industry
ENSC profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ENSC vs peers: key metrics
Top Holders
Top 5: 10.9%Adage Capital Partners GP L…
4.12%
$79K
DRW Securities, LLC
2.71%
$52K
Perceptive Advisors Llc
2.39%
$46K
Vanguard Group Inc
1.01%
$19K
HRT Financial LP
0.67%
$13K
As of Dec 31, 2025
Latest News
No related news yet